APA (7th ed.) Citation

V, F. M., K, D., A, S., AC, A., AJ, B., SN, A., . . . TM, S. (2025). Preexisting vaccine-primed heterosubtypic T cell immunity protects the maternal-fetal unit from adverse influenza outcomes in mice. The Journal of clinical investigation, 135(1), . https://doi.org/10.1172/JCI179230

Chicago Style (17th ed.) Citation

V, Flores Malavet, Dhume K, Satchmei A, Arvelo AC, Beaird AJ, Annamalai SN, Kimball LA, McKinstry KK, and Strutt TM. "Preexisting Vaccine-primed Heterosubtypic T Cell Immunity Protects the Maternal-fetal Unit from Adverse Influenza Outcomes in Mice." The Journal of Clinical Investigation 135, no. 1 (2025). https://doi.org/10.1172/JCI179230.

MLA (9th ed.) Citation

V, Flores Malavet, et al. "Preexisting Vaccine-primed Heterosubtypic T Cell Immunity Protects the Maternal-fetal Unit from Adverse Influenza Outcomes in Mice." The Journal of Clinical Investigation, vol. 135, no. 1, 2025, https://doi.org/10.1172/JCI179230.